Steinbach D - Search Results

1

An integrative functional genomic and gene expression approach revealed SORBS2 as a putative tumour suppressor gene involved in cervical carcinogenesis.

Backsch C, Rudolph B, Steinbach D, Scheungraber C, Liesenfeld M, Häfner N, Hildner M, Habenicht A, Runnebaum IB, Dürst M. Backsch C, et al. Among authors: steinbach d. Carcinogenesis. 2011 Jul;32(7):1100-6. doi: 10.1093/carcin/bgr093. Epub 2011 May 19. Carcinogenesis. 2011. PMID: 21602178

2

PRAME gene expression in childhood acute lymphoblastic leukemia.

Steinbach D, Viehmann S, Zintl F, Gruhn B. Steinbach D, et al. Cancer Genet Cytogenet. 2002 Oct 1;138(1):89-91. doi: 10.1016/s0165-4608(02)00582-4. Cancer Genet Cytogenet. 2002. PMID: 12419593

3

A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women.

Hansel A, Steinbach D, Greinke C, Schmitz M, Eiselt J, Scheungraber C, Gajda M, Hoyer H, Runnebaum IB, Dürst M. Hansel A, et al. Among authors: steinbach d. PLoS One. 2014 Mar 19;9(3):e91905. doi: 10.1371/journal.pone.0091905. eCollection 2014. PLoS One. 2014. PMID: 24647315 Free PMC article.

4

RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.

Häfner N, Steinbach D, Jansen L, Diebolder H, Dürst M, Runnebaum IB. Häfner N, et al. Among authors: steinbach d. Int J Cancer. 2016 Jan 1;138(1):217-28. doi: 10.1002/ijc.29690. Epub 2015 Jul 28. Int J Cancer. 2016. PMID: 26175272

5

Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.

Kritsch D, Hoffmann F, Steinbach D, Jansen L, Mary Photini S, Gajda M, Mosig AS, Sonnemann J, Peters S, Melnikova M, Thomale J, Dürst M, Runnebaum IB, Häfner N. Kritsch D, et al. Among authors: steinbach d. Int J Cancer. 2017 Oct 15;141(8):1600-1614. doi: 10.1002/ijc.30860. Epub 2017 Jul 12. Int J Cancer. 2017. PMID: 28670762

6

Clinical implications of PRAME gene expression in childhood acute myeloid leukemia.

Steinbach D, Hermann J, Viehmann S, Zintl F, Gruhn B. Steinbach D, et al. Cancer Genet Cytogenet. 2002 Mar;133(2):118-23. doi: 10.1016/s0165-4608(01)00570-2. Cancer Genet Cytogenet. 2002. PMID: 11943337

7

BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia.

Steinbach D, Sell W, Voigt A, Hermann J, Zintl F, Sauerbrey A. Steinbach D, et al. Leukemia. 2002 Aug;16(8):1443-7. doi: 10.1038/sj.leu.2402541. Leukemia. 2002. PMID: 12145683

8

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.

Steinbach D, Wittig S, Cario G, Viehmann S, Mueller A, Gruhn B, Haefer R, Zintl F, Sauerbrey A. Steinbach D, et al. Blood. 2003 Dec 15;102(13):4493-8. doi: 10.1182/blood-2002-11-3461. Epub 2003 Jun 19. Blood. 2003. PMID: 12816874 Free article.

9

Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia.

Steinbach D, Schramm A, Eggert A, Onda M, Dawczynski K, Rump A, Pastan I, Wittig S, Pfaffendorf N, Voigt A, Zintl F, Gruhn B. Steinbach D, et al. Clin Cancer Res. 2006 Apr 15;12(8):2434-41. doi: 10.1158/1078-0432.CCR-05-2552. Clin Cancer Res. 2006. PMID: 16638849

10

Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells.

Steinbach D, Onda M, Voigt A, Dawczynski K, Wittig S, Hassan R, Gruhn B, Pastan I. Steinbach D, et al. Eur J Haematol. 2007 Oct;79(4):281-6. doi: 10.1111/j.1600-0609.2007.00928.x. Epub 2007 Sep 4. Eur J Haematol. 2007. PMID: 17803679

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters